Pharma Lab CRO ApS — Credit Rating and Financial Key Figures
CVR number: 40729364
Søbyvej 11, 2650 Hvidovre
itmgtconsulting@gmail.com
tel: 24342655
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 384.08 | -2 676.14 | - 768.46 | 3 393.13 | |
| Wages and salaries | - 584.25 | ||||
| Social security expenses | -25.06 | ||||
| Employee benefit expenses | -1 584.11 | -1 700.80 | -3 506.72 | ||
| Other operating expenses | -69.18 | ||||
| Total depreciation | -76.27 | - 135.92 | |||
| EBIT | -76.27 | 1 774.78 | -4 465.35 | -2 469.26 | - 113.59 |
| Other financial income | 9.73 | 337.34 | |||
| Other financial expenses | 258.66 | -12.21 | -19.03 | -1.66 | - 106.50 |
| Income from other inv. held as non-curr. assets | - 708.07 | ||||
| Pre-tax profit | - 525.68 | 1 762.56 | -4 484.37 | -2 461.19 | 117.25 |
| Income taxes | 115.65 | - 399.77 | 2.64 | ||
| Net earnings | - 410.03 | 1 762.56 | -4 884.15 | -2 458.55 | 117.25 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 543.66 | 407.75 | |||
| Tangible assets total | 543.66 | 407.75 | |||
| Investments total | 78.28 | 85.58 | 87.72 | ||
| Non-current other receivables | 78.28 | 78.28 | |||
| Long term receivables total | 78.28 | 78.28 | |||
| Inventories total | |||||
| Current trade debtors | 57.62 | 6 173.06 | 1 050.64 | 11.18 | |
| Current amounts owed by group member comp. | 10 000.00 | 10 700.00 | 9 852.69 | 10 927.67 | 11 662.87 |
| Prepayments and accrued income | 271.83 | 135.92 | |||
| Current other receivables | 315.24 | 797.19 | 1 039.43 | 1 342.24 | |
| Short term receivables total | 10 057.62 | 17 188.29 | 11 700.51 | 12 250.11 | 13 141.03 |
| Cash and bank deposits | 2 348.21 | 918.01 | 236.55 | 2 516.27 | 477.91 |
| Cash and cash equivalents | 2 348.21 | 918.01 | 236.55 | 2 516.27 | 477.91 |
| Balance sheet total (assets) | 12 484.10 | 18 728.24 | 12 423.08 | 14 851.96 | 13 706.66 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | 820.06 | 410.03 | 2 172.99 | -2 711.16 | -5 169.71 |
| Profit of the financial year | - 410.03 | 1 762.56 | -4 884.15 | -2 458.55 | 117.25 |
| Shareholders equity total | 450.03 | 2 212.59 | -2 671.16 | -5 129.71 | -5 012.46 |
| Non-current advances received | 12 000.00 | 16 400.00 | |||
| Non-current liabilities total | 12 000.00 | 16 400.00 | |||
| Advances received | 14 750.00 | 19 750.00 | 16 565.15 | ||
| Current trade creditors | 123.88 | 42.46 | 25.00 | ||
| Current owed to group member | 1 005.47 | ||||
| Short-term deferred tax liabilities | 115.65 | 127.66 | |||
| Other non-interest bearing current liabilities | 34.08 | 92.71 | 189.22 | 1 123.50 | |
| Current liabilities total | 34.08 | 115.65 | 15 094.24 | 19 981.67 | 18 719.12 |
| Balance sheet total (liabilities) | 12 484.10 | 18 728.24 | 12 423.08 | 14 851.96 | 13 706.66 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.